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The effect of technical details of percutaneous catheter drainage on the clinical outcomes
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Background/aim: This study aimed to investigate the effect of technical details of percutaneous catheter drainage (PCD) on the clinical
outcomes of patients with infected necrotizing pancreatitis (INP).
Materials and methods: A total of 44 INP patients treated in our hospital from October 2013 to October 2015 were included. The
correlations of the first PCD treatment data and the clinical outcomes were analyzed.
Results: The number of catheters was positively correlated with hospital readmission (r = 0.335, P = 0.032). Receiver operating
characteristic curve analysis showed that patients with ≥ 3 catheters were more likely to have hospital readmission. Patients with pleural
effusion undergoing thoracentesis were more likely to have new intensive care unit admission (P = 0.025) and bleeding in need of
intervention (P = 0.032). Patients with more effusion regions had higher incidences of mortality (P = 0.012) and new intensive care unit
admissions (2.44 ± 1.03 vs. 1.88 ± 0.80; P = 0.059). Patients with PCD only were less likely to have new intensive care unit admissions
(22.22% vs. 54.55%; P = 0.038) than those with PCD + small incision or/and videoscopic assisted retroperitoneal debridement.
Conclusion: Number of catheters greater than three was associated with unfavorable outcomes of PCD treatment in INP patients.
Patients that received PCD treatment only had better outcomes.
Key words: Infected necrotizing pancreatitis, percutaneous catheter drainage, videoscopic assisted retroperitoneal debridement, prognosis

1. Introduction
Acute necrotizing pancreatitis is the most severe form
of acute pancreatitis characterized by focal macroscopic
or diffuse necrosis in pancreatic parenchyma or/and the
peripancreatic tissues [1]. Approximately up to 30% of
necrotizing pancreatitis patients develop a secondary
infection in pancreatic necrosis [2], which is known as
infected necrotizing pancreatitis (INP) [3].
With the advancement of minimally invasive
techniques, the “step-up” approach has been developed
for INP treatment [4]. The step-up approach adopts
minimally invasive interventions to control the source
of pancreatic infection, and a progressive strategy to
remove the necrotic and infected tissues [4]. Percutaneous
catheter drainage (PCD) is the first step in the step-up
approach. If the clinical symptoms are not relieved or poor
drainage is present at 72 h after PCD treatment, other
drainage locations or multiple drainages can be considered
for the PCD treatment. A metaanalysis including 384
patients from 11 studies shows that 55.7% of patients with

necrotizing pancreatitis can be treated with PCD without
the need for surgical necrosectomy [5].
Even though the step-up approach is widely accepted
as the primary treatment strategy for INP, there is no
consensus on the technical details of PCD such as the
timing of primary PCD, number of catheters, drain size,
and total number of drainage procedures [6]. On the other
hand, the reported therapeutic outcomes after primary
PCD for INP also markedly vary among studies [7–11],
which might be attributed to the different PCD strategies
utilized. The impact of different PCD strategies on the
clinical outcomes remains not fully understood. Therefore,
the purpose of this study was to investigate the effect of
technical details of PCD on the clinical outcomes of INP
patients.
2. Materials and methods
2.1. Patients
A total of 44 INP patients treated in our hospital from
October 2013 to October 2015 were included in this study.
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Classification, staging, pathological type, severity, and
local complications of acute pancreatitis were defined and
diagnosed according to the 2012 revision of the Atlanta
Classification of acute pancreatitis [12]. Inclusion criteria
were: 1) suspected or confirmed diagnosis of INF; 2)
PCD as initial treatment; 3) combined with pancreatic
effusion of >100 mL. Exclusion criteria included: 1) mild
acute pancreatitis; 2) PCD was not the initial treatment; 3)
pancreatic pseudocyst.
2.2. Data collection
The following baseline characteristics were collected:
sex, age, and disease etiology. Also, clinical parameters
including length of hospital stay, length of intensive care
unit (ICU) stay, and total number of hospitalizations were
collected.
The following information about the first PCD
treatment was collected: timing of first PCD procedure
(between necrotizing pancreatitis onset and PCD
treatment), number of catheters, drain locations, total
number of drainage procedures, maximal catheter size,
total number of effusion regions (including pleural effusion,
splenic effusion, hepatic effusion, iliac fossa effusion,
peripancreatic effusion), receiving abdominocentesis or
thoracentesis.
The clinical outcomes after PCD collected for
evaluation were open necrosectomy, new ICU admission,
hospital readmission, bleeding in need for intervention,
new-onset (multi)organ failure, and mortality.

Table 1. Patients’ demographic and clinical characteristics.
Parameters

Mean ±
SD or N (%)

Sex
Male

23 (52.27)

Female

21 (47.73)

Age, year

47.39 ± 14.69

Cause of pancreatitis
Trauma

1 (2.27)

Biliary

13 (29.55)

Hyperlipidemia

7 (15.91)

Alcoholic

6 (13.64)

Post-ERCP

2 (4.55)

Others

15 (34.09)

Interval between NP onset and PCD, days

31.67 ± 20.85

1 month as cut-off
≤1 month

28 (65.12)

>1 month

15 (34.88)

21 days as cut-off
≤21 days

17 (39.53)

>21 days

26 (60.47)

Number of catheters, N

3.30 ± 1.96

2.3. Statistical analysis
Continuous data were presented as the mean ± standard
deviation (SD). Means were compared by Student’s
independent t-test. The Mann–Whitney tests were
used if normality of continuous data was not assumed.
Categorical data were presented as number and percentage
and were compared by chi-square test or Fisher’s exact test
if the expected value was found lower than 5. Correlation
coefficient analyses were adopted to observe the
associations between independent variables. ROC analysis
was used to analyze the association between independent
continuous variables and major outcomes. All statistical
analyses were performed using IBM SPSS Version 20
(SPSS Statistics V20, IBM Corporation, Somers, New York,
USA). Two-tailed significance level was set at P < 0.05.

Single or multiple
Single catheter

6 (13.64)

Multiple catheters

38 (86.36)

3 as cut-off
Catheters <3

27 (61.36)

Catheters ≥3

17 (38.64)

Catheter locations
Left retroperitoneal

14 (51.85)

Right and middle retroperitoneal

13 (48.15)

Total number of drainage procedures, N

3.68 ± 2.47

Maximal catheter size, French

29.64 ± 7.60

Total number of effusion regions, N

2.11 ± 0.97

Abdominocentesis

14 (31.82)

3. Results

Thoracentesis

11 (25.00)

3.1. Patients’ demographic and clinical characteristics
A total of 44 patients receiving PCD (mean age 47.39 ±
14.69 years) were included in this study, including 23 males
(52.27%) and 22 females (47.73%). The demographic and
clinical characteristics, as well as the outcomes, were
summarized in Table 1. The mean total number of effusion
regions was 2.11 ± 0.97. The mean interval between NP

Length of hospital stay, days

55.80 ± 37.32

Length of ICU stay, days

18.95 ± 22.20

Total number of hospitalizations, times

3.16 ± 2.06

1080

Abbreviations: SD, standard deviation; ERCP, endoscopic
retrograde
cholangiopancreatography;
NP,
necrotizing
pancreatitis; ICU, intensive care unit.
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onset and PCD was 31.67 ± 20.85 days. As shown in Table
2, all patients were treated with four different interventions,
including PCD alone (45.45%), PCD + videoscopic assisted
debridement (VARD) (11.36%), PCD + small incision
(VARD via middle abdominal incision, 36.36%), and
PCD + small incision + VARD (6.82%). As for PCD, the
majority of patients (86.36%) underwent multiple catheter
insertions, and the mean number of catheters was 3.30 ±
1.96. The total number of drainage procedures was 3.68 ±
2.47. There were 14 (31.82%) and 11 (25%) cases requiring
abdominocentesis and thoracentesis, respectively. The
mean duration of hospitalization and ICU stay were 55.80
± 37.32 days and 18.95 ± 22.20 days, respectively.
3.2. Clinical outcomes after PCD
The clinical outcomes after PCD were summarized in
Table 3. After primary PCD treatment, 28 (68.29%)
and 16 (40%) cases needed hospital readmission and
new ICU admission, respectively. The mean number of
hospitalizations was 3.16 ± 2.06 times. Seventeen (43.59%)
cases needed open necrosectomy and 6 (14.29%) cases had
bleeding needing intervention. Three (7.14%) patients had
new-onset (multi)organ failure, and 4 (9.09%) patients
died.
3.3. Correlations between drainage characteristics and
clinical outcomes
The effects of drainage characteristics on the clinical
outcomes were investigated. The number of catheters was
positively correlated with hospital readmission (r = 0.335,
P = 0.032). Receiver operating characteristic (ROC) curve
analysis showed that patients with ≥3 catheters were more
likely to have hospital readmission (area under curve
(AUC) = 0.705, sensitivity = 0.750, specificity = 0.538,
Youden’s index = 0.288) than those with <3 catheters (P
= 0.037, Figure). Patients with multiple catheters had a
slight but not significant lower mortality rate as compared
with those with a single catheter (7.89% vs. 16.67%;
P = 0.487). Patients with necrosectomy had a smaller
maximal catheter size (27.06 ± 9.11 F vs. 31.82 ± 5.72 F;
P = 0.053, marginal significance). Patients with right or
middle retroperitoneal drainage had a higher rate of open
necrosectomy than those with left retroperitoneal drain
(54.55% vs. 16.67%; P = 0.089, marginal significance).
3.4. Correlation between abdominocentesis, thoracentesis, effusion, and clinical outcomes
Patients with or without abdominocentesis had comparable
clinical outcomes (all P > 0.05). However, patients
with thoracentesis were more likely to have new ICU
admissions (70% vs. 30%; P = 0.025) and bleeding needing
intervention (36.36% vs. 6.45%; P = 0.032). Patients with
more effusion regions had higher mortality (3.25 ± 0.50 vs.
2.00 ± 0.93; P = 0.012) and need for new ICU admission
(2.44 ± 1.03 vs. 1.88 ± 0.80; P = 0.059).

Table 2. Intervention methods.
Interventions

N (%)

PCD

20 (45.45)

PCD + small incision

16 (36.36)

PCD + VARD

5 (11.36)

PCD + small incision + VARD

3 (6.82)

Intervention groups
PCD only

20 (45.45)

PCD + small incision or/and VARD

24 (54.55)

PCD, percutaneous catheter drainage; small incision, videoscopic
assisted debridement via middle abdominal incision; VARD,
videoscopic assisted retroperitoneal debridement.

Table 3. Clinical outcomes after PCD.
Clinical outcomes

N (%)

Need for necrosectomy

17 (43.59)

Need for new ICU admission

16 (40.00)

Need for hospital readmission

28 (68.29)

Bleeding in need of intervention

6 (14.29)

New-onset (multi)organ failure

3 (7.14)

Mortality

4 (9.09)

Abbreviations: PCD, percutaneous catheter drainage; ICU,
intensive care unit.

3.5. Correlation between intervention methods and clinical outcomes
Next, we analyzed the association between intervention
methods and clinical outcomes. The results showed that
patients with PCD only had a significantly lower rate of
new ICU admissions (22.22% vs. 54.55%, P = 0.038) than
those with PCD + small incision or/and VARD.
The length of hospital stay was positively correlated
with length of ICU stay (r = 0.476, P = 0.001) and patient’s
age (r = 0.310, P = 0.040).
4. Discussion
Several recent studies investigating the predictive factors
of the clinical outcomes of PCD have been reported.
Hollemans et al. have demonstrated that male sex,
multiple organ failure, increasing percentage of pancreatic
necrosis, and heterogeneity of the collection are negative
predictors for success of catheter drainage in infected
necrotizing pancreatitis [13]. Cao et al. have demonstrated
that a reduction in fluid collection by <50% following
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Figure. Receiver operating characteristic (ROC) curve analysis
for the effect of number of catheters on hospital readmission.

PCD, peripancreatic necrosis of >50%, and multiple organ
failure are predictive factors for necrosectomy in INP
patients following PCD failure [14]. Ji et al. have revealed
that mean computed tomographic density of necrotic fluid
collection and multiple-organ failure are independent
pre-PCD and post-PCD risk factors for the need of
necrosectomy following PCD. However, studies on the
effect of technical details of PCD on the clinical outcomes
of INP patients are limited.
In this study, we investigated the effect of technical
details of PCD on the clinical outcomes of INP patients.
The results showed that there was a positive correlation
between the number of catheters and hospital readmission.
ROC curve analysis showed that patients with ≥3
catheters were more likely to have hospital readmission
as compared with those with <3 catheters. Patients with
open necrosectomy had a smaller mean maximal catheter
size in primary PCD (P = 0.053, marginal significance).
Patients undergoing left retroperitoneal drain were less
likely to need open necrosectomy than those with right
or middle retroperitoneal drain (P = 0.089, marginal
significance). Patients needing thoracentesis were more
likely to have new ICU admission and bleeding in need
of intervention. Patients with more effusion regions had
higher incidences of mortality and new ICU admissions
(2.44 ± 1.03 vs. 1.88 ± 0.80; P = 0.059). Patients receiving
PCD only had significantly lower rates of need for
necrosectomy and new ICU admission than those with
PCD + small incision or/and VARD. Taken together, our
results showed that number of catheters, maximal catheter
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size, and thoracentesis may affect the clinical outcomes of
PCD treatment in INP patients. Patients treated with PCD
only had better clinical outcomes.
PCD is performed under the guide of CT, placing the
catheter percutaneously to drain the necrotic tissue around
the pancreas. PCD can control sepsis and effectively
improve the clinical outcome of patients. Accumulating
evidence has demonstrated that a considerable
proportion of NP patients receiving PCD alone do not
need additional necrosectomy. A randomized controlled
trial by Van Santvoort et al. has reported that 15 out of
43 (35%) patients were successfully treated with PCD
alone without additional necrosectomy [15]. Van Baal et
al. have demonstrated a success rate of 56% (214 out of
384 patients) for PCD treatment alone [5]. In this study,
20 out of 44 INP patients (45.45%) survived with PCD
therapy only, which is consistent with the notion that PCD
should be used as the first step in the step-up approach
and can effectively delay or even avoid necrosectomy.
Our results showed that patients treated with PCD only
had better outcomes, namely, lower rates of need for open
necrosectomy and new ICU admission than those with
PCD + small incision or/and VARD.
There is no consensus on the timing of PCD in the stepup approach. A significant variation in the timing of PCD
could be observed among the reports by different centers
[16], ranging from 9 to 55 days after the onset of symptoms
[5]. Sugimoto et al. have shown that PCD can achieve
better outcomes if proactively performed in the early stages
of necrotizing pancreatitis before the development of
severe sepsis [17]. In this study, the mean interval between
NP onset and PCD was 31.67 ± 20.85 days. Our results
showed that no correlation was found between the timing
of catheter drainage and clinical outcomes. However, due
to the small sample size of the current study, this finding
should be validated in a study with a large sample size. The
effect of the number of catheters on the clinical outcomes
is rarely reported. In this study, we found a positive
correlation between the number of catheters and the need
for hospital readmission. Multiple catheters may slightly
reduce mortality rate but increase the need for hospital
readmission. This phenomenon should be attributed to the
fact that patients with multiple catheters were more likely
to have hospital readmission for manipulation, changing,
or removal of the catheters.
Regarding the catheter size, Bruennler et al. showed
that the median drainage size and the largest drainage size
have no influence on mortality [8], which is consistent with
our findings. However, we found that a smaller maximal
catheter size in primary PCD may lead to the need for
subsequent open necrosectomy. In this study, the drainage
diameter ranged from 10 French catheters to 30 French
catheters. Likewise, Dougaz et al. have reported that PCD
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with catheter size equal to or smaller than 10 French is
an independent factor associated with PCD failure [18].
A small catheter is easily obstructed, which requires
manipulation or changing of the catheter and increases the
need for open necrosectomy. As for drainage location, left
retroperitoneal route is regarded as optimal access to the
pancreatic necrosis [19], which facilitates the laparoscopic
retroperitoneal necrosectomy in the following step. In
this study, the preferred approach was left retroperitoneal
route. Our analysis showed that patients undergoing left
retroperitoneal drainage were less likely to need open
necrosectomy as compared with those with right or middle
retroperitoneal drainage. There are more organs on the
right side than on the left side of abdominal cavity, which
makes the right retroperitoneal drainage more likely to fail,
leading to an increase in the need for open necrosectomy.
In this study, we also found that INP patients with pleural
effusion undergoing thoracentesis were more likely to have
new ICU admissions and bleeding needing intervention,
which may be attributed to the fact that INP patients with
pleural effusion were in a state of a more severe disease.

It has been shown that pleural effusion is observed in
4%–20% of patients with acute pancreatitis and is strongly
associated with severity of acute pancreatitis [20].
It should be pointed out that this study has several
limitations. Firstly, this study is a retrospective one. In
addition, the sample size is relatively small. In the future,
a well-designed prospective study with a large sample size
should be conducted to validate the findings of the current
study.
In summary, this study showed that number of catheters
greater than three was associated with unfavorable
outcomes of PCD treatment in INP patients. Patients that
received PCD treatment only had better clinical outcomes.
Our findings should aid the understanding of the effect of
technical details of PCD on the clinical outcomes of INP
patients.
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